journal article·2025-04Open access

Fam172a Mediates the Stimulation of Hypothalamic Oxytocin Neurons to Suppress Obesity‐Induced Anxiety

Baocheng Wan, Lina Zhang, Xinyu Wang, Rong Zhang, Lianxi Li, Yi Zhang, Zhuo Chen, Cheng Hu

Advanced Science· Volume 12· Issue 14

Abstract

Abstract Anxiety disorder is the most common mental disorder worldwide. Although human studies have demonstrated a positive association between obesity and anxiety disorder, the exact mechanism linking these conditions is unclear. Interestingly, oxytocin (Oxt) neurons, predominantly expressed in the hypothalamic paraventricular nucleus (PVN), play a crucial role in both obesity and anxiety. In this study, obesity can induce anxiety‐like behavior in mice, which can be ameliorated by the activation of PVN Oxt neurons. Conversely, inhibiting PVN Oxt neurons accelerate the progression of anxiety. Moreover, the family with sequence similarity 172, member A (Fam172a), an anxiety susceptibility gene, is highly expressed in the hypothalamic PVN Oxt neuron but reduce in the PVN Oxt neuron of mice in the high‐fat diet and acute restraint stress conditions. Significantly, overexpression of Fam172a in PVN Oxt neurons improve obesity‐anxiety‐like behavior in mice. In contrast, disruption of Fam172a in PVN Oxt neurons exacerbate obesity‐anxiety‐like behavior. Furthermore, this study demonstrates that Fam172a is involved in mRNA degradation in Oxt neurons by regulating the intranuclear transport of Argonaute 2, thereby influencing Oxt secretion and ultimately impacting obesity‐anxiety‐like behavior. These findings suggest that Fam172a serves as a key target of PVN Oxt neurons in the regulation of obesity‐induced anxiety.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neuroendocrine regulation and behavior · Neuroscience of respiration and sleep · Child Development and Digital Technology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Jinzhou Medical University Graduate Training Base Shanghai Sixth People's Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200233 China

School of Public Health Shanghai Jiao Tong University School of Medicine Shanghai 200025 China

School of Life Science and Technology ShanghaiTech University Shanghai 201210 China

Shanghai Diabetes Institute Shanghai Key Laboratory of Diabetes Mellitus Shanghai Clinical Center for Diabetes Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai 200233 China

Department of Endocrinology and Metabolism Fengxian Central Hospital Affiliated to Southern Medical University Shanghai 201449 China

Funding

National Natural Science Foundation of China · Postdoctoral Research Foundation of China

References (56)

Show source-provided references
1. 10.1016/S0140-6736(16)30381-610.1016/S0140-6736(16)30381-6 ↗
2. 10.1017/S003329171200147X10.1017/S003329171200147X ↗
3. 10.1016/S0140-6736(16)31678-610.1016/S0140-6736(16)31678-6 ↗
4. 10.1038/ijo.2009.25210.1038/ijo.2009.252 ↗
5. 10.1016/j.tem.2021.10.00510.1016/j.tem.2021.10.005 ↗
6. 10.1016/j.neubiorev.2017.10.01410.1016/j.neubiorev.2017.10.014 ↗
7. 10.1186/2193-1801-2-16510.1186/2193-1801-2-165 ↗
8. 10.1016/j.neubiorev.2018.11.00510.1016/j.neubiorev.2018.11.005 ↗
9. 10.1016/j.pscychresns.2011.06.00510.1016/j.pscychresns.2011.06.005 ↗
10. 10.3389/fendo.2020.0037910.3389/fendo.2020.00379 ↗
11. 10.1016/j.biopsych.2015.06.00410.1016/j.biopsych.2015.06.004 ↗
12. 10.1210/jc.2014-220610.1210/jc.2014-2206 ↗
13. 10.1111/j.0953-8194.2004.01161.x10.1111/j.0953-8194.2004.01161.x ↗
14. 10.1007/s11920-017-0819-110.1007/s11920-017-0819-1 ↗
15. 10.1016/j.ynstr.2023.10056710.1016/j.ynstr.2023.100567 ↗
16. 10.1016/j.physbeh.2018.08.00710.1016/j.physbeh.2018.08.007 ↗
17. 10.1038/npp.2017.22610.1038/npp.2017.226 ↗
18. 10.1016/j.physbeh.2015.05.02310.1016/j.physbeh.2015.05.023 ↗
19. 10.1007/978-981-32-9705-0_710.1007/978-981-32-9705-0_7 ↗
20. 10.1016/j.cub.2023.11.03710.1016/j.cub.2023.11.037 ↗
21. 10.1038/s41398-022-02236-x10.1038/s41398-022-02236-x ↗
22. Li L. · Int. J. Mol. Med. · 2010 · 26 · 483
23. 10.1530/ERC-20-018110.1530/ERC-20-0181 ↗
24. Liu W. · Int. J. Oncol. · 2023 · 63 · 1
25. 10.1242/bio.04846210.1242/bio.048462 ↗
26. 10.1016/j.cbi.2023.11035410.1016/j.cbi.2023.110354 ↗
27. 10.1096/fj.202100837RR10.1096/fj.202100837RR ↗
28. 10.26508/lsa.20230213310.26508/lsa.202302133 ↗
29. 10.1016/j.atherosclerosis.2021.08.02310.1016/j.atherosclerosis.2021.08.023 ↗
30. 10.1038/npp.2015.35710.1038/npp.2015.357 ↗
31. 10.1038/mp.2017.15910.1038/mp.2017.159 ↗
32. 10.1016/j.ejphar.2023.17630110.1016/j.ejphar.2023.176301 ↗
33. 10.1016/j.pnpbp.2012.05.01810.1016/j.pnpbp.2012.05.018 ↗
34. 10.1038/s41380-021-01283-y10.1038/s41380-021-01283-y ↗
35. 10.1016/j.neuron.2016.01.04010.1016/j.neuron.2016.01.040 ↗
36. 10.1073/pnas.171537811510.1073/pnas.1715378115 ↗
37. 10.1021/cb500286b10.1021/cb500286b ↗
38. 10.1038/ncb126510.1038/ncb1265 ↗
39. 10.21769/BioProtoc.307210.21769/BioProtoc.3072 ↗
40. 10.1016/j.cell.2016.06.00110.1016/j.cell.2016.06.001 ↗
41. 10.1016/j.cmet.2018.12.00810.1016/j.cmet.2018.12.008 ↗
42. 10.1016/j.bbi.2021.11.01810.1016/j.bbi.2021.11.018 ↗
43. 10.1016/j.physbeh.2016.11.01610.1016/j.physbeh.2016.11.016 ↗
44. Lee H. J. · Prog. Neurobiol. · 2009 · 88 · 127
45. 10.1016/j.neuron.2010.12.03610.1016/j.neuron.2010.12.036 ↗
46. 10.1016/j.neuropharm.2021.10877010.1016/j.neuropharm.2021.108770 ↗
47. 10.1080/10409238.2020.173833110.1080/10409238.2020.1738331 ↗
48. 10.1093/nar/gks145310.1093/nar/gks1453 ↗
49. 10.1038/s41467-022-34998-910.1038/s41467-022-34998-9 ↗
50. 10.1186/1742-2094-8-110.1186/1742-2094-8-1 ↗
51. 10.1016/j.celrep.2021.10986810.1016/j.celrep.2021.109868 ↗
52. 10.1007/s12264-021-00731-710.1007/s12264-021-00731-7 ↗
53. 10.1186/s13578-023-01050-210.1186/s13578-023-01050-2 ↗
54. 10.7554/eLife.6753510.7554/eLife.67535 ↗
55. 10.1073/pnas.221312011910.1073/pnas.2213120119 ↗
56. 10.1523/JNEUROSCI.3240-20.202110.1523/JNEUROSCI.3240-20.2021 ↗